Is it time for a systematic and objective assessment of knee laxity? The impact of objective knee laxity after TKA on patient-reported outcomes: a comprehensive review - Top-Institutions - MDSpire

Is it time for a systematic and objective assessment of knee laxity? The impact of objective knee laxity after TKA on patient-reported outcomes: a comprehensive review

  • By

  • Hannes Vermue

  • Victor Klincke

  • Lenka Stroobant

  • Thomas Tampere

  • Jan Victor

  • Nele Arnout

  • June 25, 2026

  • 0 min

Share

Top Institutions in Orthopedic Medicine

Brief introduction explaining scope and methodology.

  • #1

    Hospital for Special Surgery
    Hospital for Special Surgery

    New York, New York

    Key Differentiators

    • Orthopedics

  • #2

    Copenhagen University Hospital Bispebjerg
    Copenhagen University Hospital Bispebjerg

    Copenhagen, Denmark

    Key Differentiators

    • Orthopedics

  • #3

    Sint Maartenskliniek
    Sint Maartenskliniek

    Nijmegen, Netherlands

    Key Differentiators

    • Orthopedics

  • #4

    Australian Clinical Outcomes Registry National
    Australian Clinical Outcomes Registry National

    Australia, N/A

    Key Differentiators

    • Orthopedics

  • #5

    Medical University of Graz
    Medical University of Graz

    Graz, Austria

    Key Differentiators

    • Orthopedics

Original Source(s)

Is it time for a systematic and objective assessment of knee laxity? The impact of objective knee laxity after TKA on patient-reported outcomes: a comprehensive review

  • by Hannes Vermue, Victor Klincke, Lenka Stroobant, Thomas Tampere, Jan Victor, Nele Arnout

  • June 25, 2026

Related Content

Pin orthosis extension block pinning versus conservative treatment for doyle type 4B mallet fractures

Pain Linked to Arthroplasty Satisfaction

A Geneva registry study points surgeons toward residual pain over functional limitation as the outcome that tracks patient satisfaction one year after hip or knee replacement.

FDA Clears Olastrocel Trial Expansion

Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.